Internal medicine, Cardiology, Myocardial infarction, Surgery and Angioplasty are his primary areas of study. Bruce R. Brodie combines Internal medicine and MEDLINE in his studies. In his research, Ischemia is intimately related to Prospective cohort study, which falls under the overarching field of Cardiology.
Bruce R. Brodie studied Myocardial infarction and Stroke that intersect with Risk factor, Killip class and Percutaneous. The Stent, Restenosis, Embolization and Catheter research he does as part of his general Surgery study is frequently linked to other disciplines of science, such as C-reactive protein, therefore creating a link between diverse domains of science. His Angioplasty research is multidisciplinary, incorporating elements of Reperfusion therapy and Primary angioplasty.
Bruce R. Brodie spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI. His Internal medicine study frequently intersects with other fields, such as Surgery. His research in the fields of TIMI, Primary angioplasty, Electrocardiography in myocardial infarction and Intravascular ultrasound overlaps with other disciplines such as In patient.
The Myocardial infarction study combines topics in areas such as Stroke and Angioplasty. His Percutaneous coronary intervention research integrates issues from Myocardial infarction complications, Mortality rate and Coronary artery disease. Bruce R. Brodie interconnects Platelet reactivity and Culprit in the investigation of issues within Conventional PCI.
Bruce R. Brodie mainly focuses on Internal medicine, Cardiology, Percutaneous coronary intervention, Myocardial infarction and Conventional PCI. His Internal medicine research includes elements of Surgery and Drug. His Surgery research incorporates elements of Biomarker, Cohort study and Confounding.
The Cardiology study combines topics in areas such as Stent, Radiology, Prospective cohort study and Hazard ratio. His Percutaneous coronary intervention study which covers Coronary artery disease that intersects with Coronary stent. His work in the fields of Conventional PCI, such as Abciximab, overlaps with other areas such as Term.
His primary areas of study are Internal medicine, Cardiology, Percutaneous coronary intervention, Myocardial infarction and Surgery. His study in Revascularization, Bivalirudin, Conventional PCI, Hazard ratio and ST segment is carried out as part of his Internal medicine studies. His Cardiology research includes themes of Stent, Prospective cohort study and Drug.
His research in Stent intersects with topics in Intravascular ultrasound and Thrombosis. His biological study spans a wide range of topics, including Clopidogrel, Adverse effect and Renal function. His Myocardial infarction research is multidisciplinary, relying on both Stroke, Randomized controlled trial and Proportional hazards model.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis A Randomized Controlled Trial
Steven E. Nissen;E. Murat Tuzcu;Paul Schoenhagen;B. Greg Brown.
American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
Gary S Mintz;Steven E Nissen;William D Anderson;Steven R Bailey.
Journal of the American College of Cardiology (2001)
Bivalirudin during Primary PCI in Acute Myocardial Infarction
Gregg W. Stone;Bernhard Witzenbichler;Giulio Guagliumi;Jan Z. Peruga.
The New England Journal of Medicine (2008)
Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction
Cindy L. Grines;David A. Cox;Gregg W. Stone;Eulogio Garcia.
The New England Journal of Medicine (1999)
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Barry J. Maron;William J. McKenna;Gordon K. Danielson;Lukas J. Kappenberger.
European Heart Journal (2003)
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Gregg W. Stone;Bernhard Witzenbichler;Giora Weisz;Michael J. Rinaldi.
The Lancet (2013)
Facilitated PCI in patients with ST-elevation myocardial infarction.
Stephen G. Ellis;Michal Tendera;Mark A. de Belder;Ad J. van Boven.
The New England Journal of Medicine (2008)
Safety and Efficacy of Drug-Eluting and Bare Metal Stents Comprehensive Meta-Analysis of Randomized Trials and Observational Studies
Ajay J. Kirtane;Anuj Gupta;Srinivas Iyengar;Jeffrey W. Moses.
Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction Analysis From the Primary Angioplasty in Myocardial Infarction Trials
Gregg W. Stone;David Cox;Eulogio Garcia;Bruce R. Brodie.
Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial
Gregg W. Stone;John Webb;David A. Cox;Bruce R. Brodie.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: